Method and composition for reducing weight
US4446138A · kind A · utility
77Cited by
4References
8Claims
0Family size
Inventor
Key dates
| Filing date | Feb 10, 1982 |
| Grant date | May 1, 1984 |
| Priority date | — |
| Expiry date | Feb 10, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing weight by the administration of L-Dopa or a stabilized form thereof with or without a decarboxylase inhibitor and Molindone wherein Molindone acts as a potentiator to enhance the weight reducing potency of L-Dopa in warm-blooded animals. The synergistic effect of the combination of L-Dopa and Molindone reduces the required dosage of the two drugs to levels which can be tolerated by higher forms of mammals, whereas individually the dosages required to reduce weight in higher mammals is not easily tolerated and may be toxic or lead to undesirable side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.